Skip to main content

Table 3 Factors independently associated with antibiotic resistance—a multivariate regression analysis

From: The epidemiology of Helicobacter pylori resistance in a university affiliated hospital: a comparison between two time periods—a cross-sectional design

 

CLR

MET

CLR + MET

 

Adjusted OR (95% CI)

p

Adjusted OR (95% CI)

p

Adjusted OR (95% CI)

p

Late period

2.64 (1.5–4.6)

0.001

1.21 (0.65–2.21)

0.562

2.37 (1.31–4.28)

0.004

Age

1.04 (1.02–1.06)

 < 0.001

1.05 (1.03–1.08)

 < 0.001

1.06 (1.03–1.08)

 < 0.001

Male

1.37 (0.75–2.51)

0.336

1.37 (0.72–2.61)

0.336

1.16 (0.64–2.09)

0.627

DM

1.25 (0.43–3.58)

0.682

4.41 (1.09–17.82)

0.037

2.1 (0.76–5.8)

0.152

IHD

1.37 (0.25–7.48)

0.717

1.41 (0.16–12.68)

0.758

1.08 (0.23–4.97)

0.925

CHF

0.18 (0.02–1.82)

0.146

0.19 (0.01–2.78)

0.222

1.04 (0.14–7.91)

0.967

Previously treated

1.35 (0.65–2.82)

0.420

1.13 (0.5–2.55)

0.776

1.2 (0.58–2.46)

0.624

  1. CLR, clarithromycin; MET, metronidazole; LEV, levofloxacin; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; CHD, congestive heart failure; CRF, chronic renal failure